| 000 | 01502 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250517174332.0 | ||
| 264 | 0 | _c20180710 | |
| 008 | 201807s 0 0 eng d | ||
| 022 | _a0048-7449 | ||
| 024 | 7 |
_a10.4081/reumatismo.2017.953 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFassio, A | |
| 245 | 0 | 0 |
_aEffects of secukinumab on serum adipocytokines: preliminary data. _h[electronic resource] |
| 260 |
_bReumatismo _cSep 2017 |
||
| 300 |
_a105-110 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAdipokines _xblood |
| 650 | 0 | 4 |
_aAdipose Tissue, White _xmetabolism |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xpharmacology |
| 650 | 0 | 4 | _aAntibodies, Monoclonal, Humanized |
| 650 | 0 | 4 |
_aArthritis, Psoriatic _xblood |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInterleukin-17 _xantagonists & inhibitors |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMetabolic Syndrome _xcomplications |
| 650 | 0 | 4 |
_aMethotrexate _xtherapeutic use |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 | _aSex Factors |
| 700 | 1 | _aGatti, D | |
| 700 | 1 | _aGisondi, P | |
| 700 | 1 | _aGirolomoni, G | |
| 700 | 1 | _aViapiana, O | |
| 700 | 1 | _aGiollo, A | |
| 700 | 1 | _aZamboni, M | |
| 700 | 1 | _aRossini, M | |
| 700 | 1 | _aIdolazzi, L | |
| 773 | 0 |
_tReumatismo _gvol. 69 _gno. 3 _gp. 105-110 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.4081/reumatismo.2017.953 _zAvailable from publisher's website |
| 999 |
_c27587562 _d27587562 |
||